Etanercept, a tumor necrosis factor inhibitor, has been used successfully for the treatment of multiple immune-mediated inflammatory diseases including moderate-to-severe rheumatoid arthritis (RA) [1]. The gene discussed is TNF; the disease is rheumatoid arthritis.